Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakub Rohlena

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Trends in Biochemical Sciences|February 11, 2017
Mitochondrial Complex II: At the CrossroadsAyenachew Bezawork-Geleta, Jakub Rohlena, Lanfeng Dong, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 31, 2015
Evaluation of respiration of mitochondria in cancer cells exposed to mitochondria-targeted agentsKatarina Kluckova, Lan-Feng Dong, Martina Bajzikova, et al.
Mitochondrion|August 1, 2012
Classification of mitocans, anti-cancer drugs acting on mitochondriaJiri Neuzil, Lan-Feng Dong, Jakub Rohlena, et al.
Mitochondrion|June 17, 2014
Powerhouse down: Complex II dissociation in the respiratory chainMing-Shih Hwang, Jakub Rohlena, Lan-Feng Dong, et al.
Biological Chemistry|October 4, 2018
Mitochondria-driven elimination of cancer and senescent cellsSona Hubackova, Silvia Magalhaes Novais, Eliska Davidova, et al.
Frontiers in Oncology|December 30, 2022
Effects of metabolic cancer therapy on tumor microenvironmentPetra Hyroššová, Mirko Milošević, Josef Škoda, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 11, 2020
Dihydroorotate dehydrogenase in oxidative phosphorylation and cancerStepana Boukalova, Sona Hubackova, Mirko Milosevic, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 7, 2024
Aspartate in tumor microenvironment and beyond: Metabolic interactions and therapeutic perspectivesJulian Wong Soon, Maria Antonietta Manca, Agnieszka Laskowska, et al.
The Journal of Biological Chemistry|January 11, 2003
Residues Phe342-Asn346 of activated coagulation factor IX contribute to the interaction with low density lipoprotein receptor-related proteinJakub Rohlena, Joost A Kolkman, Ria C Boertjes, et al.
European Journal of Cell Biology|September 9, 2006
Limited contribution of claudin-5-dependent tight junction strands to endothelial barrier functionRuud D Fontijn, Jakub Rohlena, Jan van Marle, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Trends in Biochemical Sciences|February 11, 2017
Mitochondrial Complex II: At the CrossroadsAyenachew Bezawork-Geleta, Jakub Rohlena, Lanfeng Dong, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 31, 2015
Evaluation of respiration of mitochondria in cancer cells exposed to mitochondria-targeted agentsKatarina Kluckova, Lan-Feng Dong, Martina Bajzikova, et al.
Mitochondrion|August 1, 2012
Classification of mitocans, anti-cancer drugs acting on mitochondriaJiri Neuzil, Lan-Feng Dong, Jakub Rohlena, et al.
Mitochondrion|June 17, 2014
Powerhouse down: Complex II dissociation in the respiratory chainMing-Shih Hwang, Jakub Rohlena, Lan-Feng Dong, et al.
Biological Chemistry|October 4, 2018
Mitochondria-driven elimination of cancer and senescent cellsSona Hubackova, Silvia Magalhaes Novais, Eliska Davidova, et al.
Frontiers in Oncology|December 30, 2022
Effects of metabolic cancer therapy on tumor microenvironmentPetra Hyroššová, Mirko Milošević, Josef Škoda, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 11, 2020
Dihydroorotate dehydrogenase in oxidative phosphorylation and cancerStepana Boukalova, Sona Hubackova, Mirko Milosevic, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 7, 2024
Aspartate in tumor microenvironment and beyond: Metabolic interactions and therapeutic perspectivesJulian Wong Soon, Maria Antonietta Manca, Agnieszka Laskowska, et al.
The Journal of Biological Chemistry|January 11, 2003
Residues Phe342-Asn346 of activated coagulation factor IX contribute to the interaction with low density lipoprotein receptor-related proteinJakub Rohlena, Joost A Kolkman, Ria C Boertjes, et al.
European Journal of Cell Biology|September 9, 2006
Limited contribution of claudin-5-dependent tight junction strands to endothelial barrier functionRuud D Fontijn, Jakub Rohlena, Jan van Marle, et al.
Pageof 7